<DOC>
	<DOC>NCT00948662</DOC>
	<brief_summary>This study will assess the safety and tolerability of ascending single oral doses of SAM-760 in healthy young adult and healthy elderly subjects. The secondary objectives are to provide the concentrations of SAM-760 in the blood and to evaluate the effect of a high-fat meal on the concentrations in the blood of SAM-760 administered to healthy young adult subjects, and to evaluate the effects of concomitant administration of ketoconazole on the safety and the concentrations of SAM-760 in the blood of a single dose of SAM-760 in healthy young adult subjects.</brief_summary>
	<brief_title>Study Evaluating The Safety And Tolerability Of Administration Of Single Oral Doses Of SAM-760 To Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Men or women of nonchildbearing potential aged 18 to 50 years inclusive (healthy young subjects) and &gt; 65 years (healthy elderly subjects) at screening. Body mass index (BMI) in the range of 18 to 32 kg/m2 and body weight &gt;= 50 kg. Presence or history of any disorder that may prevent the successful completion of the study. Any surgical or medical condition that may interfere with the absorption, distribution, metabolism, or excretion of the investigational drug or placebo.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>ascending single doses</keyword>
	<keyword>healthy subjects</keyword>
</DOC>